Reduced levels of serum pigment epithelium-derived factor in women with endometriosis

Reproductive Sciences

Volumn 19, Issue 1, 2012, Pages 64-69

  Chen, Liqing ^a   Fan, Ruijia ^a   Huang, Xiufeng ^a   Xu, Hong ^a   Zhang, Xinmei ^a  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

angiogenesis; endometriosis; pigment epithelium derived factor; serum

Indexed keywords

PIGMENT EPITHELIUM DERIVED FACTOR;

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; ENDOMETRIOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN TISSUE; INFERTILITY; LAPAROSCOPIC SURGERY; MAJOR CLINICAL STUDY; PAIN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

ADULT; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; ENDOMETRIOSIS; EYE PROTEINS; FEMALE; HUMANS; NERVE GROWTH FACTORS; SERPINS;

EID: 84855423263     PISSN: 19337191     EISSN: 19337205     Source Type: Journal    
DOI: 10.1177/1933719111413300     Document Type: Article

References (53)

1. Zhang X, Lin J, Qian Y, Deng L. Decreased levels of interleukin-18 in peritoneal fluid but not in serum of patients with endometriosis. Fertil Steril. 2004 ; 81 (5). 1229-1234 (Pubitemid 38609303)
2. Xu H, Lui WT, Chu CY, Ng PS, Wang CC, Rogers MS. Anti-angiogenic effects of green tea catechin on an experimental endometriosis mouse model. Hum Reprod. 2009 ; 24 (3). 608-618
3. Cosín R, Gilabert-Estellés J, Ramón LA, et al. Influence of peritoneal fluid on the expression of angiogenic and proteolytic factors in cultures of endometrial cells from women with endometriosis. Hum Reprod. 2010 ; 25 (2). 398-405
4. Fujii EY, Nakayama M, Nakagawa A.. Concentrations of receptor for advanced glycation end products, VEGF and CML in plasma, follicular fluid, and peritoneal fluid in women with and without endometriosis. Reprod Sci. 2008 ; 15 (10). 1066-1074
5. Cho SH, Oh YJ, Nam A, et al. Evaluation of serum and urinary angiogenic factors in patients with endometriosis. Am J Reprod Immunol. 2007 ; 58 (6). 497-504 (Pubitemid 350091186)
6. Agic A, Djalali S, Wolfler MM, Halis G, Diedrich K, Hornung D.. Combination of CCR1 mRNA, MCP1, and CA125 measurements in peripheral blood as a diagnostic test for endometriosis. Reprod Sci. 2008 ; 15 (9). 906-911
7. Chae SJ, Kim H, Jee BC, Suh CS, Kim SH, Kim JG. Tumor necrosis factor (TNF)-TNF receptor gene polymorphisms and their serum levels in Korean women with endometriosis. Am J Reprod Immunol. 2008 ; 60 (5). 432-439
8. Ohata Y, Harada T, Miyakoda H, Taniguchi F, Iwabe T, Terakawa N. Serum interleukin-8 levels are elevated in patients with ovarian endometrioma. Fertil Steril. 2008 ; 90 (4). 994-999
9. Bourlev V, Iljasova N, Adamyan L, Larsson A, Olovsson M. Signs of reduced angiogenic activity after surgical removal of deeply infiltrating endometriosis. Fertil Steril. 2010 ; 94 (1). 52-57
10. Machado DE, Berardo PT, Palmero CY, Nasciutti LE. Higher expression of vascular endothelial growth factor (VEGF) and its receptor VEGFR-2 (Flk-1) and metalloproteinase-9 (MMP-9) in a rat model of peritoneal endometriosis is similar to cancer diseases. J Exp Clin Cancer Res. 2010 ; 4: 29
11. Machado DE, Berardo PT, Palmero CY, Nasciutti LE. A selective cyclooxygenase-2 inhibitor suppresses the growth of endometriosis with an antiangiogenic effect in a rat model. Fertil Steril. 2010 ; 93 (8). 2674-2679
12. Di Carlo C, Bonifacio M, Tommaselli GA, Bifulco G, Guerra G, Nappi C. Metalloproteinases, vascular endothelial growth factor, and angiopoietin 1 and 2 in eutopic and ectopic endometrium. Fertil Steril. 2009 ; 91 (6). 2315-2323
13. Becker CM, D'Amato RJ. Angiogenesis and antiangiogenic therapy in endometriosis. Microvasc Res. 2007 ; 74 ((2-3)). 121-130 (Pubitemid 350051024)
14. Tombran-Tink J, Chader GG, Johnson LV. PEDF: a pigment epithelium-derived factor with potent neuronal differentiative activity. Exp Eye Res. 1991 ; 53 (3). 411-414
15. Hoshina D, Abe R, Yamagishi SI, Shimizu H. The role of PEDF in tumor growth and metastasis. Curr Mol Med. 2010 ; 10 (3). 292-295
16. Yamagishi S, Adachi H, Abe A, et al. Elevated serum levels of pigment epithelium-derived factor in the metabolic syndrome. J Clin Endocrinol Metab. 2006 ; 91 (6). 2447-2450 (Pubitemid 43855041)
17. Yamagishi S, Matsui T, Takenaka K, Nakamura K, Takeuchi M, Hiroyoshi Inoue H. Pigment epithelium-derived factor (PEDF) prevents platelet activation and aggregation in diabetic rats by blocking deleterious effects of advanced glycation end products (AGEs). Diabetes Metab Res Rev. 2009 ; 25 (3). 266-271
18. Zhang T, Guan M, Xu C, Chen Y, Lu Y. Pigment epithelium-derived factor inhibits glioma cell growth in vitro and in vivo. Life Sci. 2007 ; 81 (16). 1256-1263 (Pubitemid 47539504)
19. Broadhead ML, Dass CR, Choong PF. In vitro and in vivo biological activity of PEDF against a range of tumors. Expert Opin Ther Targets. 2009 ; 13 (12). 1429-1438
20. Ek ET, Dass CR, Choong PF. Pigment epithelium-derived factor: a multimodal tumor inhibitor. Mol Cancer Ther. 2006 ; 5 (7). 1641-1646 (Pubitemid 44323231)
21. Wang JJ, Zhang SX, Mott R, et al. Anti-inflammatory effects of pigment epithelium-derived factor in diabetic nephropathy. Am J Physiol Renal Physiol. 2008 ; 294 (5). F1166 - F1173
22. Zhang SX, Wang JJ, Dashti A, et al. Pigment epithelium-derived factor mitigates inflammation and oxidative stress in retinal pericytes exposed to oxidized low-density lipoprotein. J Mol Endocrinol. 2008 ; 41 (3). 135-143
23. Yang H, Cheng R, Liu G, et al. PEDF inhibits growth of retinoblastoma by anti-angiogenic activity. Cancer Sci. 2009 ; 100 (12). 2419-2425
24. Yang LP, Cheng P, Peng XC, et al. Anti-tumor effect of adenovirus-mediated gene transfer of pigment epithelium-derived factor on mouse B16-F10 melanoma. J Exp Clin Cancer Res. 2009 ; 75: 28
25. Lin J, Zhang X, Chen Y. Mutagen sensitivity as a susceptibility marker for endometriosis. Hum Reprod. 2003 ; 18 (10). 2052-2057 (Pubitemid 37265065)
26. Grammatikakis I, Zervoudis S, Evangelinakis N, Tziortzioti V. Endometrium and ovarian cancer synchronous to endometriosis-a retrospective study of our experience of 7 years. J Med Life. 2010 ; 3 (1). 76-79
27. Chen L, Fan R, Huang X, Xu H, Zhang X. Decreased concentrations of pigment epithelium-derived factor in peritoneal fluid of patients with endometriosis. Fertil Steril. 2011 ; 95 (5). 1798-1800
28. Revised American Society for Reproductive Medicine classification of endometriosis 1996. Fertil Steril. 1997 ; 67 (5). 817-821
29. Stratton P, Berkley KJ. Chronic pelvic pain and endometriosis: translational evidence of the relationship and implications. Hum Reprod Update. 2011 ; 17 (3). 327-346
30. Becker CM, Wright RD, Satchi-Fainaro R, et al. A novel noninvasive model of endometriosis for monitoring the efficacy of antiangiogenic therapy. Am J Pathol. 2006 ; 168 (6). 2074-2084 (Pubitemid 43825325)
31. Hur SE, Lee JY, Moon HS, Chung HW. Angiopoietin-1, angiopoietin-2 and Tie-2 expression in eutopic endometrium in advanced endometriosis. Mol Hum Reprod. 2006 ; 12 (7). 421-426 (Pubitemid 44288200)
32. Matsuzaki S, Murakami T, Uehara S, et al. Erythropoietin concentrations are elevated in the peritoneal fluid of women with endometriosis. Hum Reprod. 2001 ; 16 (5). 945-948 (Pubitemid 32451831)
33. Elayappan B, Ravinarayannan H, Pasha SP, Lee KJ, Gurunathan S. PEDF inhibits VEGF- and EPO-induced angiogenesis in retinal endothelial cells through interruption of PI3K/Akt phosphorylation. Angiogenesis. 2009 ; 12 (4). 313-324
34. Haribalaganesh R, Sheikpranbabu S, Banumathi E, Gurunathan S. Pigment epithelium-derived factor inhibits erythropoietin-induced retinal endothelial cell angiogenesis by suppression of PI3K/Akt pathway. Exp Eye Res. 2010 ; 90 (6). 726-733
35. Sheikpranbabu S, Ravinarayanan H, Elayappan B, Jongsun P, Gurunathan S. Pigment epithelium-derived factor inhibits vascular endothelial growth factor-and interleukin-1beta-induced vascular permeability and angiogenesis in retinal endothelial cells. Vascul Pharmacol. 2010 ; 52 ((1-2)). 84-94
36. Tan ML, Choong PF, Dass CR. Anti-chondrosarcoma effects of PEDF mediated via molecules important to apoptosis, cell cycling, adhesion and invasion. Biochem Biophys Res Commun. 2010 ; 398 (4). 613-618
37. Barrier BF, Sharpe-Timms KL. Expression of soluble adhesion molecules in sera of women with stage III and IV endometriosis. J Soc Gynecol Investigl. 2002 ; 9 (2). 98-101 (Pubitemid 34234811)
38. Gmyrek GB, Sozanski R, Jerzak M, et al. Evaluation of monocyte chemotactic protein-1 levels in peripheral blood of infertile women with endometriosis. Eur J Obstet Gynecol Reprod Biol. 2005 ; 122 (2). 199-205 (Pubitemid 41428157)
39. Podgaec S, Dias Junior JA, Chapron C, Oliveira RM, Baracat EC, Abrão MS. Th1 and Th2 immune responses related to pelvic endometriosis. Rev Assoc Med Bras. 2010 ; 56 (1). 92-98
40. Lambrinoudaki IV, Augoulea A, Christodoulakos GE, et al. Measurable serum markers of oxidative stress response in women with endometriosis. Fertil Steril. 2009 ; 91 (1). 46-50
41. Jackson LW, Schisterman EF, Dey-Rao R, Browne R, Armstrong D. Oxidative stress and endometriosis. Hum Reprod. 2005 ; 20 (7). 2014-2020 (Pubitemid 40932392)
42. Ek ET, Dass CR, Contreras KG, Choong PF. PEDF-derived synthetic peptides exhibit antitumor activity in an orthotopic model of human osteosarcoma. J Orthop Res. 2007 ; 25 (12). 1671-1680 (Pubitemid 350293816)
43. Dass CR, Ek ET, Choong PF. PEDF as an emerging therapeutic candidate for osteosarcoma. Curr Cancer Drug Targets. 2008 ; 8 (8). 683-690
44. Palmieri D, Watson JM, Rinehart CA. Age-related expression of PEDF/EPC-1 in human endometrial stromal fibroblasts: implications for interactive senescence. Exp Cell Res. 1999 ; 247 (1). 142-147 (Pubitemid 29393970)
45. Cheung LW, Au SC, Cheung AN, et al. Pigment epithelium-derived factor is estrogen sensitive and inhibits the growth of human ovarian cancer and ovarian surface epithelial cells. Endocrinology. 2006 ; 147 (9). 4179-4191 (Pubitemid 44268369)
46. Stejskal D, Karpísek M, Svesták M, Hejduk P, Sporová L, Kotolová H. Pigment epithelium-derived factor as a new marker of metabolic syndrome in Caucasian population. J Clin Lab Anal. 2010 ; 24 (1). 17-19
47. Ferrero S, Gillott DJ, Anserini P, et al. Vitamin D binding protein in endometriosis. J Soc Gynecol Investig. 2005 ; 12 (4). 272-277 (Pubitemid 40615098)
48. Agic A, Xu H, Altgassen C, et al. Relative expression of 1,25-dihydroxyvitamin D3 receptor, vitamin D 1 alpha-hydroxylase, vitamin D 24-hydroxylase, and vitamin D 25-hydroxylase in endometriosis and gynecologic cancers. Reprod Sci. 2007 ; 14 (5). 486-497 (Pubitemid 351168795)
49. Pretta S, Remorgida V, Abbamonte LH, et al. Atherosclerosis in women with endometriosis. Eur J Obstet Gynecol Reprod Biol. 2007 ; 132 (2). 226-231 (Pubitemid 46817705)
50. Somigliana E, Panina-Bordignon P, Murone S, Di Lucia P, Vercellini P, Vigano P. Vitamin D reserve is higher in women with endometriosis. Hum Reprod. 2007 ; 22 (8). 2273-2278 (Pubitemid 47241875)
51. Verit FF, Erel O, Celik N. Serum paraoxonase-1 activity in women with endometriosis and its relationship with the stage of the disease. Hum Reprod. 2008 ; 23 (1). 100-104 (Pubitemid 351767315)
52. Kobayashi H, Yamada Y, Kanayama S, et al. The role of iron in the pathogenesis of endometriosis. Gynecol Endocrinol. 200 9 ; 25 (1). 39-52
53. Yamaguchi K, Mandai M, Oura T, et al. Identification of an ovarian clear cell carcinoma gene signature that reflects inherent disease biology and the carcinogenic processes. Oncogene. 20 10 ; 29 (12). 1741-1752